Pharmacovigilance for Medical Devices and IVDs: Ensuring Safety and Compliance

While pharmacovigilance (PV) is traditionally associated with medicines, medical devices and in vitro diagnostics (IVDs) also require systematic safety monitoring. With the introduction of the EU Medical Device Regulation (MDR 2017/745) and In Vitro Diagnostic Regulation (IVDR 2017/746), manufacturers must implement robust vigilance systems to detect, assess, and mitigate risks associated with device use. Regulatory authorities such as the MHRA in the UK, EMA for combination products, and global bodies are increasingly emphasising compliance in device vigilance.

What Is Device Vigilance?

Device vigilance refers to the systematic process of monitoring, reporting, and analysing adverse events and incidents related to medical devices or IVDs. It is essential for:

• Protecting patient safety
  
• Ensuring compliance with regulatory requirements
  
• Supporting product improvement and risk minimisation
  

Unlike drugs, medical devices may fail due to design, manufacturing, or user-related issues. Therefore, vigilance focuses on adverse events, device malfunctions, and near misses.

Key Regulatory Requirements

1. EU MDR & IVDR
   
   • Manufacturers must maintain a vigilance system for reporting serious incidents and field safety corrective actions (FSCAs).
     
   • Reports must be submitted to the Competent Authority within specified timelines: 2 days for death/serious deterioration, 10 days for serious incidents.
     
2. UK MDR
   
   • The MHRA requires manufacturers to report adverse incidents through the Yellow Card Scheme for medical devices.
     
   • Manufacturers must implement a system to document, investigate, and prevent recurrence.
     
3. Global Regulations
   
   • Other jurisdictions (FDA, Health Canada, TGA) have similar reporting obligations for medical devices.
     

Key Elements of Medical Device Pharmacovigilance

A robust device vigilance system typically includes:

1. Adverse Event Reporting
   
   • Capture incidents from healthcare professionals, patients, and internal quality systems.
     
   • Classify events by seriousness, severity, and likelihood of recurrence.
     
2. Risk Assessment and Root Cause Analysis
   
   • Evaluate device failures using risk management standards such as ISO 14971.
     
   • Identify patterns and potential design or process flaws.
     
3. Field Safety Corrective Actions (FSCA)
   
   • Issue recalls, safety notices, or updates to mitigate identified risks.
     
   • Track effectiveness of corrective actions.
     
4. Documentation and Traceability
   
   • Maintain device history files (DHF) and vigilance reports.
     
   • Ensure traceability from adverse events to corrective action.
     
5. Training and SOPs
   
   • Ensure staff are trained in incident reporting and risk management.
     
   • Maintain standard operating procedures aligned with MDR/IVDR and local requirements.
     

Challenges in Device Pharmacovigilance

• Data heterogeneity: Reports may vary in completeness and quality.
  
• Complex supply chains: Multiple manufacturers and distributors complicate accountability.
  
• Integration with quality management systems: Ensuring seamless connection between vigilance and QMS.
  
• Timely reporting: Meeting strict regulatory timelines is critical to avoid non-compliance.
  
• Emerging technologies: Software as a medical device (SaMD) and combination products require specialised vigilance approaches.
  

Best Practices for Compliance

1. Implement a centralised device vigilance database for tracking incidents.
   
2. Maintain regular audit trails for reporting and investigations.
   
3. Integrate vigilance with the Quality Management System (ISO 13485).
   
4. Conduct periodic risk assessments and post-market surveillance.
   
5. Engage with regulatory authorities proactively for guidance and reporting clarity.
   
6. Train personnel regularly on incident reporting, root cause analysis, and FSCA procedures.
   

How Q&V Supports Medical Device and IVD Vigilance

Q&V provides expert pharmacovigilance services tailored for medical devices and IVDs, including:

• End-to-end incident reporting and case management
  
• Field Safety Corrective Action (FSCA) planning and tracking
  
• Regulatory compliance with MHRA, EU MDR/IVDR, and global authorities
  
• Integration with quality management systems and CAPA processes
  
• Audit preparation and inspection readiness
  

Our experienced team ensures manufacturers meet regulatory expectations while maintaining patient safety and operational efficiency.